Trader: Low Volume ...
Health Care: Drugs
A.P. Pharma Inc. (APPA: OTC)
$0.58 0.00 | 0.00%
06/04/12 - 10:32 AM ET
Ratio Comparisons
| Company | Industry | S&P 500 | |
| Valuation Ratios | |||
|---|---|---|---|
| P/E Ratio (TTM) | n.a. | 17.40 | 17.70 |
| P/E High - Last 5 Yrs | n.a. | 19.50 | 67.70 |
| P/E Low - Last 5 Yrs | n.a. | 8.60 | 12.50 |
| Beta | 0.55 | 0.58 | 0.98 |
| Price to Sales (TTM) | 458.27 | 2.34 | 1.42 |
| Price to Book (MRQ) | 9.89 | 2.46 | 2.41 |
| Price to Tangible Book (MRQ) | 9.89 | 19.23 | 5.08 |
| Price to Cash Flow (TTM) | -7.70 | 9.60 | 9.80 |
| Price to Free Cash Flow (TTM) | -9.80 | 89.50 | 17.40 |
| Dividends | |||
| Dividend Yield (%) | 0.00 | 4.40 | 2.10 |
| Dividend Yield - 5 Yr Avg (%) | n.a. | 3.50 | 2.20 |
| Dividend 5 Yr Growth Rate (%) | n.a. | 5.99 | -0.76 |
| Payout Ratio (TTM) | 0.00 | 69.00 | 30.00 |
| Sales (MRQ) vs Qtr 1 Yr Ago (%) | -100.00 | 23.90 | 11.80 |
| Sales (TTM) vs TTM 1 Yr Ago (%) | -50.30 | 12.50 | 9.20 |
| Growth Rates (%) | |||
| Sales - 5 Yr Growth Rate (%) | n.a. | 4.23 | 1.79 |
| EPS (MRQ) vs Qtr 1 Yr Ago (%) | n.a. | 61.90 | 17.50 |
| EPS (TTM) vs TTM 1 Yr Ago (%) | n.a. | 61.90 | 17.50 |
| EPS - 5 Yr Growth Rate (%) | n.a. | 0.81 | -1.66 |
| Capital Spending - 5 Yr Growth Rate (%) | -14.34 | 14.94 | -1.17 |
| Financial Strength | |||
| Quick Ratio (MRQ) | 4.00 | 1.40 | 1.10 |
| Current Ratio (MRQ) | 4.10 | 1.80 | 1.60 |
| LT Debt to Equity (MRQ) | 0.00 | 0.36 | 0.82 |
| Total Debt to Equity (MRQ) | 0.01 | 0.46 | 0.96 |
| Interest Coverage (TTM) | n.a. | 12.00 | 5.50 |
| Profitability Ratios (%) | |||
| Gross Margin (TTM) | n.a. | 77.40 | 46.90 |
| Gross Margin - 5 Yr Avg | n.a. | 78.40 | 47.70 |
| EBITD Margin (TTM) | n.a. | 30.50 | 18.90 |
| EBITD - 5 Yr Avg | -434.66 | 0.00 | 0.00 |
| Pre-Tax Margin (TTM) | n.a. | 21.30 | 12.10 |
| Pre-Tax Margin - 5 Yr Avg | n.a. | 23.10 | 10.30 |
| Management Effectiveness (%) | |||
| Net Profit Margin (TTM) | -59.56 | 0.17 | 0.09 |
| Net Profit Margin - 5 Yr Avg | n.a. | 19.00 | 7.00 |
| Return on Assets (TTM) | -102.10 | 7.40 | 3.10 |
| Return on Assets - 5 Yr Avg | -90.50 | 9.80 | 2.50 |
| Return on Investment (TTM) | -131.00 | 11.50 | 7.90 |
| Return on Investment - 5 Yr Avg | -118.00 | 15.70 | 6.50 |
| Efficiency | |||
| Revenue/Employee (TTM) | 13,211.00 | 548,710.00 | 449,376.00 |
| Net Income/Employee (TTM) | -806,105.00 | 91,547.00 | 39,003.00 |
| Receivable Turnover (TTM) | 1.90 | 4.90 | 7.60 |
| Inventory Turnover (TTM) | n.a. | 1.90 | 8.30 |
| Asset Turnover (TTM) | 0.00 | 0.50 | 0.40 |
Portfolios with APPA
- Portfolio NameUser Type
- UserMy Folio
- Userwatchlist1
- UserMARK 1 C
- ContributorBarron's Insider Purchases ...
- UserSUPRATRADE-2709091838
- UserLatest Activist Filings 2-2...
- ContributorBarron's Insider Purchases ...
- ContributorBarron's Insider Purchases ...
- ContributorBarron's Insider Purchases ...
- UserBarron's Insider Purchases ...
Latest APPA Headlines from TheStreet
- Ambac Financial, QAD: Early Volume Plays 05.18.10 | 08:05 am
- A.P. Pharma, Netlist: Early Volume Plays 03.19.10 | 10:03 am
- Biotech Stock Mailbag: Sequenom 03.12.10 | 07:03 am
- Latest News in Activist Investing 02.26.09 | 11:02 am
- Insider Action: Trading Level 3 10.03.08 | 12:10 pm
- Monday's Small-Cap Winners & Losers 06.25.07 | 04:06 pm
- Thursday's Health Winners & Losers 12.21.06 | 01:12 pm
- Monday's Small-Cap Winners & Losers 10.02.06 | 03:10 pm
Press Releases for APPA
- A.P. Pharma Announces Study Finding Continuous Exposure To A 5-HT3 Antagonist Using APF530 Provides Better Emetic Control - Business Wire 05.31.12 | 08:05 am
- A.P. Pharma Announces First Quarter 2012 Financial Results And Recent Corporate Progress - Business Wire 05.10.12 | 08:05 am
- A.P. Pharma Announces Third Quarter 2011 Financial Results And Recent Corporate Progress - Business Wire 11.07.11 | 08:11 am
- LifeSci Advisors Announces Investment Opinion On A.P. Pharma Inc. - Business Wire 08.29.11 | 01:08 pm
- A.P. Pharma Announces Second Quarter 2011 Financial Results And Reports On Recent Corporate Progress - Business Wire 08.08.11 | 08:08 am
- A.P. Pharma To Raise $24 Million In Private Placement Of Common Stock And Warrants - Business Wire 06.29.11 | 08:06 am
- A.P. Pharma Announces First Quarter 2011 Financial Results And Recent Corporate Progress - Business Wire 05.16.11 | 08:05 am
- A.P. Pharma Announces Financing Of Up To $4.5 Million And Names CEO And COO - Business Wire 04.25.11 | 08:04 am
- A.P. Pharma Provides Regulatory Update On APF530 NDA - Business Wire 04.25.11 | 08:04 am
- A.P. Pharma Announces Transfer To OTCQB - Business Wire 03.31.11 | 06:03 am
Partner Headlines for APPA
- Mannkind Slashes Staff: Biotech's Latest Tribulations - Seeking Alpha 02.13.11 | 08:02 am
- UPDATE 3-FDA denies approval of AP Pharma nausea drug; shrs sink - Reuters 03.19.10 | 12:03 pm
